Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hsu YF
------>authors3_c=
------>paper_class1=1
------>Impact_Factor=2.371
------>paper_class3=2
------>paper_class2=1
------>vol=46
------>confirm_bywho=hsuan
------>insert_bywho=juansh
------>Jurnal_Rank=49.0
------>authors4_c=
------>comm_author=
------>patent_EDate=None
------>authors5_c=
------>publish_day=1
------>paper_class2Letter=None
------>page2=83
------>medlineContent=
------>unit=E0105
------>insert_date=20070425
------>iam=5
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=
------>authors_c=
------>score=500
------>journal_name=Mol Carcinog.
------>paper_name=Involvement of Ras/Raf-1/ERK actions in the magnolol-induced upregulation of p21 and cell-cycle arrest in colon cancer cells.
------>confirm_date=20070504
------>tch_id=090103
------>pmid=17295239
------>page1=275
------>fullAbstract=Previously, we showed that magnolol induces cell-cycle arrest in cultured colon and liver cancer cells through an upregulation of the p21 protein. The aim of this study was to delineate the molecular mechanism underlying this magnolol-induced increase of p21 protein. Thus our RT-PCR analysis demonstrated that the mRNA levels of p21 were increased at 1 h after magnolol treatment and sustained for at least 24 h. The p21 promoter activity was also increased by magnolol treatment. Western blot analysis demonstrated that treatment of COLO-205 cells with magnolol increased the levels of phosphorylation of extracellular signal-regulated kinase (ERK). Pretreatment of the cells with PD98059 abolished the magnolol-induced upregulation of p21 protein, suggesting the involvement of an ERK pathway in the magnolol-induced upregulation of p21 in COLO-205 cells. Ras inhibitor peptide abolished the magnolol-induced increase of phosphorylated ERK protein levels, increase of p21 protein, and decrease of thymidine incorporation. Moreover, treatment of COLO-205 with magnolol increased the phosphorylated Raf-1 protein (the Ras target molecule). Pretreatment of the cells with Raf-1 inhibitor reversed the magnolol-induced decrease in thymidine incorporation. Treatment of the cells with CaM kinase inhibitor, but not protein kinase A (PKA) inhibitor or phosphatidylinosital 3-kinase (PI3K) inhibitor, abolished the magnolol-induced activation of ERK and decrease of thymidine incorporation. Taken together, our results suggest that magnolol activates ERK phosphorylation through a Ras/Raf-1-mediated pathway. Subsequently, p21 expression is increased, and finally thymidine incorporation is decreased.
------>tmu_sno=None
------>sno=15158
------>authors2=Lee TS
------>authors3=Lin SY
------>authors4=Hsu SP
------>authors5=Juan SH
------>authors6=Hsu YH, Zhong WB, Lee WS
------>authors6_c=
------>authors=Hsu YF
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=
------>publish_area=0
------>updateTitle=Involvement of Ras/Raf-1/ERK actions in the magnolol-induced upregulation of p21 and cell-cycle arrest in colon cancer cells.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=4
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2007
------>submit_flag=None
------>publish_month=4
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z